Bank Of New York Mellon Corp Vera Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$15.74 - $22.19 $1.13 Million - $1.59 Million	71,770 New	71,770 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$13.27 - $22.31 $74,126 - $124,623	-5,586 Reduced 7.44%	69,498 $1.48 Million
Q2 2022 Aug 15, 2022	BUY	$12.82 - $23.4 $336,499 - $614,203	26,248 Added 53.75%	75,084 $1.02 Million
Q1 2022 May 11, 2022	BUY	$17.8 - $28.06 $502,796 - $792,610	28,247 Added 137.19%	48,836 $1.15 Million
Q4 2021 Feb 11, 2022	BUY	$15.01 - $35.8 $110,548 - $263,667	7,365 Added 55.69%	20,589 $550,000
Q3 2021 Nov 12, 2021	BUY	$13.71 - $30.6 $181,301 - $404,654	13,224 New	13,224 $230,000

185

55.6M

134K

156K

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $1.03B
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.